Exact Mass: 275.028393
Exact Mass Matches: 275.028393
Found 48 metabolites which its exact mass value is equals to given mass value 275.028393,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-(2-formyl-3-chlorophenyl)anthranilic acid
N-(2-formyl-3-chlorophenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.
Lorcaserin sulfamate
Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)
Meticrane
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
(5R)-3-Ethylsulfanyl-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
7,8-Dihydroxy-3-(2-methyl-thiazol-4-yl)-chromen-4-one
Ethyl2-amino-2-[2-(2,4-dichlorophenyl)hydrazono]-acetate
N-(4-Bromophenyl)-N-(1-phenylethyl)amine
C14H14BrN (275.03095440000004)
3-HYDROXYMETHYL-6-(2-NITROPHENYL)IMIDAZO[2,1-B]THIAZOLE
4-chloro-1-(3-nitrophenyl)pyrazolo[3,4-d]pyrimidine
5-methyl-3-phenyl-2-sulfanylidene-4H-[1,3]thiazolo[4,5-d]pyrimidin-7-one
6-AMINO-5-BROMO-1-ISOBUTYL-3-METHYL-1H-PYRIMIDINE-2,4-DIONE
2-(2-CHLORO-ACETYLAMINO)-4,5-DIMETHYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER
4-Chloro-1-(4-nitrophenyl)-1H-pyrazolo[3,4-d]pyrimidine
2-(5-nitrothiophen-2-yl)-2,3-dihydro-1H-quinazolin-4-one
methyl 3-(pyrrolidin-1-ylsulfonyl)thiophene-2-carboxylate
4-chloro-6-(4-methylphenyl)-2-(methylthio)pyrimidine-5-carbonitrile
(4,5-dimethoxy-2-nitrophenyl)methyl carbonochloridate
C10H10ClNO6 (275.01966300000004)
4-(CHLOROMETHYL)-5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)OXAZOLE
3-piperidin-1-ylsulfonylthiophene-2-carboxylic acid
2-(2-bromophenyl)-N,N-dimethylaniline
C14H14BrN (275.03095440000004)
2-[(3-chlorophenyl)methylsulfanyl]-3H-imidazo[4,5-c]pyridine
Meticrane
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
Lorcaserin sulfamate
Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)